Insight Widest with the analysis. We look at the companies others don’t, giving access to the opportunities others won’t.

Deep dive : Health

Valeo Pharma making progress as it bids to become leading...

The company is focused, though not exclusively, in the fields of neuro-degenerative diseases, cancer and...

Giles Gwinnett

18.00 Thu 25 Feb 2021

Insight : Health

PsyBio Therapeutics is pioneering the next generation of targeted...

1 day, 4 hours ago

Deep dive : Health

Pan-Biome Pharmaceuticals aims for the gut to fight chronic...

1 day, 7 hours ago

Deep dive : Health

Medexus Pharmaceuticals has a potential company-maker in Treosulfan

1 day, 23 hours ago

Deep dive : Health

AIM ImmunoTech developing immuno-therapeutics to treat multiple...

2 days, 1 hour ago

Show all Insight news

Deep dive We explore the investor case for growth companies

Health

Acasti Pharma awaiting business review outcome after CaPre drug trial...

3 days, 1 hour ago

Health

Psyched Wellness is pioneering research into the health benefits of Amanita...

4 days, 6 hours ago

Health

Numinus Wellness looking to position itself at the forefront of psychedelics...

1 week ago

Health

Open Orphan to start first-ever coronavirus challenge trial

1 week ago

Watch: director interviews Hear from the directors whose companies are making the new

Health

Bionomics' positive pharmacokinec results confirms it can begin...

2 hours, 51 minutes ago

Health

Benchmark Holdings 'end first quarter on positive note, good...

3 hours, 24 minutes ago

Health

XPhyto Therapeutics achieves first purchases for their 25 minute...

22 hours, 25 minutes ago

Health

Universal Ibogaine names Dr Rami Batal as the company’s new CEO

1 day, 23 hours ago

Opinion We bridge the gap between knowledge and ignorance and give you the angle that hard facts alone won’t

Health

The Dow Jones hits the magic 30,000, as more stimulus looms and easing continues

on 27/11/20

Retail & consumer

When did you get so big? Billion-pound companies that maybe you thought weren't

on 3/10/19

Feature We give you the knowledge and tools to understand and take on the market

Health

COVID-19 tests may become more frequent as Boris Johnson suggests rapid...

1 week, 3 days ago

Health

Highlight Therapeutics: on a mission to extend benefits of immuno-oncology drugs

on 29/1/21

Mining

The lithium market recovers its poise, as demand soars and prices rise

on 28/1/21

Health

Faron Pharmaceuticals enjoys momentum as COVID-19 drug candidate gets green...

on 26/1/21

Research Independent research from the expert Proactive analyst team

Health

Strategic Minerals

SourceBio International: Back with a Bang

Health

Proactive Analyst Emma...

Health

Shield Therapeutics: US...

Health

Shield Therapeutics: US...

Shield Therapeutics PLC (STX) has updated on its commercialisation plan for the US...

Health

Open Orphan: Sustaining...

Meet the real story
Proactive One2One Virtual Forum

BeProactive

Retail & consumer

Australian stocks recover all early 2020 losses – just

on 30/12/20

Health

Are small-cap biotech stocks good investments now?

on 14/8/20

Health

siRNA technology: targeting diseases at the root

on 13/4/20

Health

Immuno-oncology: All you wanted to know but were too afraid to ask

on 20/1/20

Finance

Two minute explainer: illegal market manipulation

on 12/8/19

Sections

Sections

Sections

Sections

Insight Widest with the analysis. We look at the companies others don’t, giving access to the opportunities others won’t.

Valeo Pharma making progress as it bids to become leading...

Giles Gwinnett

Deep dive We explore the investor case for growth companies

Acasti Pharma awaiting business review outcome after CaPre drug trial...

Psyched Wellness is pioneering research into the health benefits of Amanita...

Numinus Wellness looking to position itself at the forefront of psychedelics...

Open Orphan to start first-ever coronavirus challenge trial

Watch: director interviews Hear from the directors whose companies are making the new

Bionomics' positive pharmacokinec results confirms it can begin...

Benchmark Holdings 'end first quarter on positive note, good...

XPhyto Therapeutics achieves first purchases for their 25 minute...

Universal Ibogaine names Dr Rami Batal as the company’s new CEO

Opinion We bridge the gap between knowledge and ignorance and give you the angle that hard facts alone won’t

The Dow Jones hits the magic 30,000, as more stimulus looms and easing continues

When did you get so big? Billion-pound companies that maybe you thought weren't

Feature We give you the knowledge and tools to understand and take on the market

COVID-19 tests may become more frequent as Boris Johnson suggests rapid...

Highlight Therapeutics: on a mission to extend benefits of immuno-oncology drugs

The lithium market recovers its poise, as demand soars and prices rise

Faron Pharmaceuticals enjoys momentum as COVID-19 drug candidate gets green...

Research Independent research from the expert Proactive analyst team

Strategic Minerals

Proactive Analyst Emma...

Shield Therapeutics: US...

Shield Therapeutics: US...

Open Orphan: Sustaining...

Meet the real story
Proactive One2One Virtual Forum

BeProactive

Retail & consumer

Australian stocks recover all early 2020 losses – just

Are small-cap biotech stocks good investments now?

siRNA technology: targeting diseases at the root

Immuno-oncology: All you wanted to know but were too afraid to ask

Two minute explainer: illegal market manipulation

Sections

Sections

Sections

Sections

Insight Widest with the analysis. We look at the companies others don’t, giving access to the opportunities others won’t.

Giles Gwinnett

Deep dive We explore the investor case for growth companies

Watch: director interviews Hear from the directors whose companies are making the new

Opinion We bridge the gap between knowledge and ignorance and give you the angle that hard facts alone won’t

Feature We give you the knowledge and tools to understand and take on the market

Research Independent research from the expert Proactive analyst team

Meet the real story Proactive One2One Virtual Forum

London 04 March 2021

BeProactive

Meet the real story
Proactive One2One Virtual Forum

London
04 March 2021